ATRAptarGroup, Inc.
Price
-9.4%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality mixed, no red flags, price roughly fair, growth steady, the market undecided.
Aptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. Aptar serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care and home care. Using proprietary design, engineering, materials science, and manufacturing capabilities, Aptar supports customers across these end markets by enabling safe, functional, and differentiated product and service delivery.
In the company’s own words · 10-K filed Feb 6, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
AptarGroup, Inc. (ATR) reported revenue of $1.03B in Q2 2026 (quarter ended Jun 30, 2026), up 6.3% from the same quarter a year earlier. That came with a gross margin of 36% and net income of $88M (8.6% of revenue). For the full year FY2025, revenue was $3.78B (+5.4% year on year) and net income $392M. Its largest segment in Q2 2026 was Pharma at $231M, 44% of the disclosed total, just ahead of Beauty at 42%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 10, 2026On September 4, 2026, Aditya J. Gandhi, Vice President, Chief Accounting Officer of AptarGroup, Inc. (the “Company”), notified the Company of his decision to resign from his positions as Vice President, Chief Accounting Officer and principal accounting officer of the Company, effective on September 11, 2026 (the …Director or officer change · Form 8-K
- Sep 1, 2026On August 29, 2026, the Board of Directors (the “Board”) of AptarGroup, Inc. (the “Company”) increased the size of the Board from ten (10) to eleven (11) directors and appointed Gael Touya as a director, effective as of September 1, 2026.Director or officer change · Form 8-K
- May 13, 2026On May 10, 2026, AptarGroup, Inc. (the “Company”) appointed Aditya J. Gandhi as Vice President, Chief Accounting Officer of the Company, effective June 8, 2026 (the “Effective Date”)Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Q2 2026 · $521.0MThe company’s own SEC segment disclosure.
- Pharma$230.7M44%
- Beauty$221.2M42%
- Closures$69.1M13%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
Ranks #1 of 21 by RyuScore